FK506 (tacrolimus) interacts with FKBP12, activates Smad1/5/8 with or without BMPR2 mutations, recovers endothelial dysfunction, and ameliorates PH53–55. The gene discussed is FKBP1A; the disease is endothelial dysfunction.